B · Normal
[Huadong Medicine: Subsidiary's registration application for semiconductor laser therapy device was accepted] On September 14th, Huadong Medicine (000963.SZ) announced that the company's wholly-owned subsidiary High Technology Products, S.L.U. received an "Acceptance Notice" issued by the State Food and Drug Administration, and its application for registration of the Class III medical device semiconductor laser therapy device Primelase was accepted. This product has been approved for market access in many countries and regions around the world and is used to remove unwanted hair and treat benign skin vascular lesions. This acceptance will not have a significant impact on the company's recent operating results.
Comments